Completed OBSERVATIONAL NCT01574235

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Safety of Nivestim® in Patients Treated With Neutropenia-inducing Anticancer Chemotherapy in Routine Practice

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer

Conditions Chemotherapy-induced Febrile Neutropenia (FN) Malignant Hemopathy Solid Tumors

Interventions Nivestim®

Updated 8 times since 2017 Last updated: Jul 27, 2015 Started: Oct 31, 2011 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chemotherapy-induced Febrile Neutropenia (FN) and Malignant Hemopathy and is currently completed. Hospira, now a wholly owned subsidiary of Pfizer leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
May 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — May 2017 [monthly]

Completed NA

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospira, now a wholly owned subsidiary of Pfizer

Data source: Hospira, now a wholly owned subsidiary of Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aix-en-Provence, France , Aix-les-Bains, France , Alès, France , Angers, France , Annecy, France , Argenteuil, France , Arras, France , Avignon, France , Boulogne, France , Bourg-en-Bresse, France and 57 more locations